Background Radiofrequency ablation (RFA) is a standard treatment for small inoperable
hepatocellular carcinoma (HCC). Studies on mid-and long-term outcome of RFA as first-line …

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular
carcinoma (HCC) and identify survival-and recurrence-related factors. METHODS …

Purpose To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line
therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic …

BACKGROUND & AIMS: The aim was to assess 10-year outcomes of radiofrequency
ablation as a first-line therapy of early-stage hepatocellular carcinoma with an analysis of …

The purpose of this study was to evaluate the long-term survival results and complications of
percutaneous radiofrequency ablation (RFA) in patients with early-stage hepatocellular …

Abstract Background and Aims: We evaluated the prognosis and associated factors in
patients with small hepatocellular carcinoma (HCC; up to 3 nodules, each up to 3cm in …

Objectives. It remains unclear whether radiofrequency ablation (RFA) provides comparable
outcomes to surgical resection (SR). We, therefore, compared survival outcomes of RFA to …

Background Despite the high complete necrosis rate of radiofrequency ablation (RFA),
tumor recurrence, either local tumor recurrence or new tumor formation, remains a …

Radiofrequency ablation (RFA) has been used as a curative therapy for small hepatocellular
carcinoma (HCC). However, relatively little is known about the long-term outcome of RFA for …

Objective. To compare percutaneous ethanol injection (PEI), the standard approach which
has been used for many years to treat early non-surgical hepatocellular carcinoma (HCC) in …